126 related articles for article (PubMed ID: 38520219)
1. Comprehensive evaluation of cytomorphologic, histologic, and molecular features of DICER1-altered thyroid lesions on FNA: A multipractice experience.
Lengyel K; Lubin DJ; Hsiao WY; Sirotnikov S; Luo G; Roberts JW; Shi Q; Magliocca K; Lewis MM; Sears DL; Ilyas G; Rogers BB; Viswanathan K
Cancer Cytopathol; 2024 Jun; 132(6):359-369. PubMed ID: 38520219
[TBL] [Abstract][Full Text] [Related]
2. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology-histopathology correlation in 7 patients.
Darbinyan A; Morotti R; Cai G; Prasad ML; Christison-Lagay E; Dinauer C; Adeniran AJ
Cancer Cytopathol; 2020 Oct; 128(10):746-756. PubMed ID: 32897650
[TBL] [Abstract][Full Text] [Related]
3. Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases.
Jitpasutham T; Andrianus S; Gubbiotti M; Nosé V; Baloch ZW; Madrigal E; Faquin WC
Cancer Cytopathol; 2024 Jun; 132(6):370-385. PubMed ID: 38558329
[TBL] [Abstract][Full Text] [Related]
4. Cytomorphologic features of thyroid nodules harboring thyroid adenoma-associated fusion: A single institutional review of 11 cases.
Roberts JW; Lubin DJ; Shi Q; Viswanathan K
Diagn Cytopathol; 2022 Jul; 50(7):327-334. PubMed ID: 35347884
[TBL] [Abstract][Full Text] [Related]
5. An institutional experience with DICER1 mutated thyroid nodules-evaluating the cytomorphology and molecular phenotype.
Lee SH; Vadlamudi C; Zhao Q; Yilmaz O; Cerda S
J Am Soc Cytopathol; 2022; 11(6):335-344. PubMed ID: 35934646
[TBL] [Abstract][Full Text] [Related]
6. Malignant teratomas of the thyroid gland: clinico-radiologic and cytomorphologic features of a rare entity.
Miller DL; Thompson LDR; Bishop JA; Rooper LM; Ali SZ
J Am Soc Cytopathol; 2020; 9(4):221-231. PubMed ID: 32448730
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.
Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R
Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
[TBL] [Abstract][Full Text] [Related]
9. Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?
Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
Cytopathology; 2021 Jan; 32(1):37-44. PubMed ID: 32803788
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
Wong KS; Angell TE; Strickland KC; Alexander EK; Cibas ES; Krane JF; Barletta JA
Thyroid; 2016 Jul; 26(7):911-5. PubMed ID: 27219469
[TBL] [Abstract][Full Text] [Related]
11. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
Hyeon J; Ahn S; Shin JH; Oh YL
Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
[TBL] [Abstract][Full Text] [Related]
12. Thyroblastoma: A DICER1-associated embryonal neoplasm and fine needle aspiration diagnostic criteria.
Jitpasutham T; Faquin WC; Torous VF; Nosé V
Diagn Cytopathol; 2023 May; 51(5):E142-E148. PubMed ID: 36688366
[TBL] [Abstract][Full Text] [Related]
13. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis.
Strickland KC; Vivero M; Jo VY; Lowe AC; Hollowell M; Qian X; Wieczorek TJ; French CA; Teot LA; Sadow PM; Alexander EK; Cibas ES; Barletta JA; Krane JF
Thyroid; 2016 Oct; 26(10):1466-1471. PubMed ID: 27457786
[TBL] [Abstract][Full Text] [Related]
15. Defining thyroid spherules: A benign cytomorphologic feature that mimics microfollicles.
Costigan DC; Shaar M; Frates MC; Alexander EK; Barletta JA; Cibas ES
Cancer Cytopathol; 2020 Mar; 128(3):171-176. PubMed ID: 31856389
[TBL] [Abstract][Full Text] [Related]
16. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
[TBL] [Abstract][Full Text] [Related]
17. Semiquantitative assessment of cytomorphologic features can predict mutation status of thyroid nodules with indeterminate cytologic diagnosis.
Shahi M; Bloechl SJ; Vogel RI; Shrestha R; Krigman HR; Evasovich M; Burmeister LA; Amin K
Hum Pathol; 2019 Nov; 93():81-89. PubMed ID: 31437520
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
[TBL] [Abstract][Full Text] [Related]
19. Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.
Chandler JB; Colunga M; Prasad ML; Callender GG; Quinn C; Chhieng D; Adeniran AJ
Cancer Cytopathol; 2017 Nov; 125(11):865-875. PubMed ID: 28834409
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
